Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 8, Issue 2, pp. 246-254
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 15, 2019
- Revision received August 26, 2019
- Accepted December 9, 2019
- Published first December 18, 2019.
Article Versions
- Previous version (December 18, 2019 - 08:14).
- Previous version (January 14, 2020 - 06:05).
- You are viewing the most recent version of this article.
Copyright & Usage
©2019 American Association for Cancer Research.
Author Information
- Samantha K. Greaney1,
- Alain P. Algazi1,2,
- Katy K. Tsai1,2,
- Kathryn T. Takamura3,
- Lawrence Chen1,
- Christopher G. Twitty3,
- Li Zhang2,
- Alan Paciorek2,
- Robert H. Pierce3,4,
- Mai H. Le3,
- Adil I. Daud1,2,*, and
- Lawrence Fong1,2,*
- 1Division of Hematology and Oncology, University of California, San Francisco, San Francisco, California.
- 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.
- 3OncoSec Medical Incorporated, San Diego, California.
- 4University of Washington, Seattle, Washington.
- ↵*Corresponding Authors:
Lawrence Fong, University of California, San Francisco, 513 Parnassus Avenue, Room HSE301A, San Francisco, CA 94143-0519. Phone: 415-514-3160; Fax: 415-476-0459; E-mail: Lawrence.Fong{at}ucsf.edu; and Adil I. Daud, University of California, San Francisco, 550 16th Street, Room MS6809, San Francisco, CA 94158. E-mail: adil.daud{at}ucsf.edu
February 2020
Volume 8, Issue 2
Volume 8, Issue 2
Intratumoral Plasmid IL12 Electroporation Therapy in Patients with Advanced Melanoma Induces Systemic and Intratumoral T-cell Responses
Jump to section
Advertisement